The association between low diastolic blood pressure in middle age and cognitive function in old age. A population-based study

Age and Ageing

Volumn 29, Issue 3, 2000, Pages 243-248

  Kilander, Lena ^a   Nyman, Håkan ^b   Boberg, Merike ^a   Lithell, Hans ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Cognitive function; Risk factor; Trail making test; Verbal fluency

Indexed keywords

AGE; AGED; AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN CORTEX; BRAIN FUNCTION; CEREBROVASCULAR DISEASE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EDUCATION; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; LEARNING; LINGUISTICS; MALE; MEMORY; OCCUPATION; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOMETRY; RISK FACTOR; SWEDEN;

EID: 0034021087     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/29.3.243     Document Type: Article

References (26)

1. MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke and coronary heart disease, part 1. Lancet 1990; 335: 765-74.
2. Kilander L, Nyman H, Hansson I, et al. Hypertension and associated metabolic disturbances are related to cognitive impairment A 20-year follow-up of 999 men. Hypertension 1998; 31: 780-86.
3. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
4. Lezak M. Neuropsychological Assessment, 3rd edition. New York: Oxford University Press, 1995.
5. Amar K, Bucks RS, Lewis T et al. The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age Ageing 1996: 25: 443-8.
6. Ylikoski R, Ylikoski A, Erkinjuntti T et al. White matter changes in healthy elderly correlate with attention and speed of mental processing. Arch Neurol 1993; 50: 818-24.
7. Breteler MM, van Amerongen NM, van Swieten JC et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke 1994; 25: 1109-15.
8. Schmidt R, Fazekas F. Offenbacher H et al. Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers Neurology 1993; 43: 2490-4.
9. DeCarli C, Murphy DGM, Tranh M et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995; 45: 2077-84.
10. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039.
11. Wechsler D. Wechsler Adult Intelligence Scale - revised. San Antonio: The Psychological Corporation, 1981.
12. Claeson L-E, Dahl E. The Claeson-Dahl learning test for clinical use. Stockholm: Psykologiförlaget, 1971 [In Swedish].
13. Kaplan E, Fein D, Morris R et al. WAIS-R NI. Manual. San Antonio: The Psychological Corporation, 1991.
14. Elias MF, Wolf PA, D'Agostino RB et al. Untreated blood pressure is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993; 138: 353-64.
15. Launer L, Masaki K, Petrovitch H et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia aging study. JAMA 1995; 274: 1846-51.
16. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-5.
17. Longstreth WT, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 1996; 27: 1274-82.
18. Breteler M, Claus J, Grobbee D et al. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. Br Med J 1994; 308: 1604-8.
19. Kalmijn S, Feskens EJM, Launer LJ et al. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38: 1096-102.
20. Ott A, Breteler M, de Bruyne M et al. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 1997; 28: 316-21.
21. Kilander L, Andrén B, Nyman H et al. Atrial fibrillation is an independent determinant of low cognitive function. A cross-sectional study in elderly men. Stroke 1998; 29: 1816-20.
22. Richards M, Meade TW, Peart S et al. Is there any evidence for a protective effect of antithrombotic medication on cognitive function in men at risk of cardiovascular disease? Some preliminary findings. J Neurol Neurosurg Psychiatr 1997; 62: 269-72.
23. Goldstein G, Materson BJ, Cushman WC et al. Treatment of hypertension in the elderly: II. Cognitive and behavioural function. Hypertension 1990; 15: 361-69.
24. Applegate WB, Pressel S, Wittes J et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Arch Int Med 1994; 154: 2154-60.
25. Prince MJ, Bird AS, Blizard RA et al. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. Br Med J 1996; 312: 801-5.
26. Forette F, Seux M-L, Staessen JA et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347-51.